Assessing onset, prevalence and survival in mice using a frailty phenotype

Cory W. Baumann, Dongmin Kwak, La Dora V. Thompson

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Little is known whether frailty assessments in mice are capable of distinguishing important characteristics of the frailty syndrome. The goals of this study were to identify the onset and the prevalence of frailty across the lifespan and to determine if a frailty phenotype predicts mortality. Body weight, walking speed, strength, endurance and physical activity were assessed in male C57BL/6 mice every three months starting at 14 months of age. Mice that fell in the bottom 20% for walking speed, strength, endurance and physical activity, and in the top 20% for body weight were considered to have a positive frailty marker. The onset of frailty occurred at 17 months, and represented only 3.5% of the mouse cohort. The percentage of frail mice increased with age until basically every mouse was identified as frail. Frail, pre-frail, and non-frail mice had mean survival ages of 27, 29 and 34 months, respectively. In closing, frail mice lack resilience; in that, multiple tissue/organ systems may deteriorate at an accelerated rate and ultimately lead to early mortality when compared to non-frail mice. Identifying the onset and prevalence of frailty, in addition to predicting mortality, has potential to yield information about several aging processes.

Original languageEnglish (US)
Pages (from-to)4042-4053
Number of pages12
JournalAging
Volume10
Issue number12
DOIs
StatePublished - Dec 1 2018

Keywords

  • Aging
  • Disease
  • Function
  • Muscle
  • Obesity
  • Physiology

Fingerprint Dive into the research topics of 'Assessing onset, prevalence and survival in mice using a frailty phenotype'. Together they form a unique fingerprint.

  • Cite this

    Baumann, C. W., Kwak, D., & Thompson, L. D. V. (2018). Assessing onset, prevalence and survival in mice using a frailty phenotype. Aging, 10(12), 4042-4053. https://doi.org/10.18632/aging.101692